Daniel Grosslight Analyst PerformanceSenior Research Analyst at CitigroupDaniel Grosslight is a stock analyst at Citigroup focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Daniel Grosslight has issued 85 stock ratings, including buy, hold, and sell recommendations. While full access to Daniel Grosslight's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Grosslight's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings105 Last 6 YearsBuy Recommendations58.25% 60 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution103RatingsDistribution of strong buy, buy, hold, and sell ratings by Daniel Grosslight.RatingPercentageCount Strong Buy0.0%0 ratings Buy58.3%59 ratings Hold35.0%36 ratings Sell6.8%7 ratingsOut of 103 total stock ratings issued by Daniel Grosslight at Citigroup, the majority (58.3%) have been Buy recommendations, followed by 35.0% Hold and 6.8% Sell.Best & Worst CallsBest Call000.0%MCKJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EVHJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE61.5% of companies on NYSE16 companiesNASDAQ38.5% of companies on NASDAQ10 companiesDaniel Grosslight, an analyst at Citigroup, currently covers 26 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare25 companies96.2%Finance1 company3.8%Daniel Grosslight of Citigroup specializes in stock coverage within the Healthcare sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES10 companies38.5%HEALTHCARE TECHNOLOGY7 companies26.9%HEALTHCARE EQUIPMENT & SUPPLIES4 companies15.4%PHARMACEUTICALS3 companies11.5%LIFE SCIENCES TOOLS & SERVICES1 company3.8%INSURANCE1 company3.8% Daniel Grosslight's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCAHCardinal Health8/12/2026Boost Price Target$237.26$280.00Buy$0.0000.00% ROIHIMSHims & Hers Health8/11/2026Lower Price Target$31.19$33.00Neutral$0.0000.00% ROIGDRXGoodRx8/11/2026Boost Price Target$3.81$5.00Buy$0.0000.00% ROIHCATHealth Catalyst8/11/2026Lower Price Target$1.79$2.00Neutral$0.0000.00% ROIZTSZoetis8/11/2026Lower Price Target$75.24$96.00Buy$0.0000.00% ROIACHAccendra Health8/10/2026Downgrade$1.40$1.50Neutral$0.0000.00% ROIAGLAgilon Health8/10/2026Upgrade$97.23$115.00Neutral$0.0000.00% ROIEVHEvolent Health8/10/2026Upgrade$3.93$6.00Buy$0.0000.00% ROICTEVClaritev8/10/2026Reiterated Rating$32.00$45.00Buy$0.0000.00% ROICORCencora8/6/2026Reiterated Rating$317.68Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IDXXIDEXX Laboratories8/5/2026Boost Price Target$588.09$670.00Neutral$0.0000.00% ROIHSICHenry Schein8/5/2026Reiterated Rating$89.11$112.00Buy$0.0000.00% ROIBIOBio-Rad Laboratories8/5/2026Boost Price Target$345.35$330.00Hold$0.0000.00% ROITDOCTeladoc Health8/3/2026Lower Price Target$6.63$7.50Neutral$0.0000.00% ROIMCKMcKesson7/24/2026Boost Price Target$824.71$1,000.00Buy$0.0000.00% ROICAHCardinal Health7/24/2026Boost Price Target$225.54$265.00Buy$0.0000.00% ROIACHAccendra Health7/24/2026Lower Price Target$3.12$4.50Buy$0.0000.00% ROIHIMSHims & Hers Health7/23/2026Boost Price Target$31.69$35.00Neutral$0.0000.00% ROIHCATHealth Catalyst7/23/2026Reiterated Rating$2.04Neutral$0.0000.00% ROIGDRXGoodRx7/23/2026Reiterated Rating$2.93Buy$0.0000.00% ROIAGLAgilon Health7/23/2026Downgrade$120.42$105.00Sell$0.0000.00% ROIEVHEvolent Health7/23/2026Reiterated Rating$5.57$6.75Sell$0.0000.00% ROIEVHEvolent Health7/23/2026Reiterated Rating$5.57$6.75Sell$0.0000.00% ROIWAYWaystar7/20/2026Reiterated Rating$22.27Buy$0.0000.00% ROICAHCardinal Health7/2/2026Reiterated Rating$238.32Buy$0.0000.00% ROIGMRSGMR Solutions6/7/2026Initiated Coverage$10.94$17.00Buy$0.0000.00% ROIPHRPhreesia5/29/2026Reiterated Rating$9.45Market Perform$0.0000.00% ROIPHRPhreesia5/28/2026Boost Price Target$9.15$12.00Neutral$0.0000.00% ROIZTSZoetis5/18/2026Lower Price Target$77.30$112.00Buy$0.0000.00% ROIEVHEvolent Health5/15/2026Boost Price Target$4.09$5.50Buy$0.0000.00% ROIAGLAgilon Health5/15/2026Reiterated Rating$78.10$80.00Neutral$0.0000.00% ROIGDRXGoodRx5/14/2026Boost Price Target$2.61$4.00Buy$0.0000.00% ROIPAHCPhibro Animal Health5/14/2026Lower Price Target$36.48$44.00Neutral$0.0000.00% ROIMCKMcKesson5/14/2026Lower Price Target$748.15$945.00Buy$0.0000.00% ROIACHAccendra Health5/12/2026Boost Price Target$3.93$5.00Buy$0.0000.00% ROIHIMSHims & Hers Health5/12/2026Boost Price Target$29.12$28.00Neutral$0.0000.00% ROIELANElanco Animal Health5/7/2026Boost Price Target$24.07$31.00Buy$0.0000.00% ROICORCencora5/7/2026Lower Price Target$254.90$355.00Buy$0.0000.00% ROIWAYWaystar5/5/2026Lower Price Target$20.79$30.00Buy$0.0000.00% ROITDOCTeladoc Health5/5/2026Boost Price Target$6.75$7.00Neutral$0.0000.00% ROIHere’s the stock symbol I’ve promised (Ad)Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.Get the stock name and ticker symbol free of charge todayCAHCardinal Health5/1/2026Lower Price Target$193.21$245.00Buy$0.0000.00% ROIZTSZoetis4/15/2026Initiated Coverage$121.11$145.00Buy$0.0000.00% ROIPAHCPhibro Animal Health4/15/2026Initiated Coverage$59.02$62.00Neutral$0.0000.00% ROIIDXXIDEXX Laboratories4/15/2026Initiated Coverage$584.05$650.00Neutral$0.0000.00% ROIHSICHenry Schein4/15/2026Initiated Coverage$77.20$100.00Buy$0.0000.00% ROINVSTEnvista4/15/2026Initiated Coverage$27.37$29.00Neutral$0.0000.00% ROIXRAYDENTSPLY SIRONA4/15/2026Initiated Coverage$12.22$10.00Sell$0.0000.00% ROIALGNAlign Technology4/15/2026Initiated Coverage$184.69$240.00Buy$0.0000.00% ROIELANElanco Animal Health4/15/2026Initiated Coverage$24.12$30.00Buy$0.0000.00% ROIALGNAlign Technology4/15/2026Initiated Coverage$185.02$240.00Buy$0.0000.00% ROIHSICHenry Schein4/15/2026Initiated Coverage$77.21$100.00Buy$0.0000.00% ROIIDXXIDEXX Laboratories4/15/2026Initiated Coverage$569.95$650.00Hold$0.0000.00% ROINVSTEnvista4/15/2026Initiated Coverage$26.91$29.00Hold$0.0000.00% ROIPAHCPhibro Animal Health4/15/2026Initiated Coverage$53.88$62.00Hold$0.0000.00% ROIXRAYDENTSPLY SIRONA4/15/2026Initiated Coverage$12.09$10.00Sell$0.0000.00% ROIZTSZoetis4/15/2026Initiated Coverage$119.15$145.00Buy$0.0000.00% ROIPHRPhreesia3/31/2026Reiterated Rating$11.43$10.00Neutral$0.0000.00% ROIHCATHealth Catalyst3/13/2026Lower Price Target$1.32$1.75Neutral$0.0000.00% ROIHIMSHims & Hers Health3/10/2026Upgrade$22.12$24.00Neutral$0.0000.00% ROITDOCTeladoc Health3/3/2026Lower Price Target$5.09$6.00Neutral$0.0000.00% ROIPRVAPrivia Health Group3/3/2026Lower Price Target$23.58$32.00Buy$0.0000.00% ROIGDRXGoodRx3/3/2026Lower Price Target$2.06$3.50Buy$0.0000.00% ROIAGLAgilon Health3/3/2026Lower Price Target$13.64$18.75Neutral$0.0000.00% ROIEVHEvolent Health2/26/2026Lower Price Target$3.34$4.00Buy$0.0000.00% ROICTEVClaritev2/25/2026Lower Price Target$13.48$21.00Buy$0.0000.00% ROIHIMSHims & Hers Health2/24/2026Lower Price Target$15.56$13.25Sell$0.0000.00% ROIWAYWaystar2/18/2026Lower Price Target$25.31$35.00Buy$0.0000.00% ROIHIMSHims & Hers Health2/9/2026Lower Price Target$17.31$16.50Sell$0.0000.00% ROICAHCardinal Health1/9/2026Upgrade$202.63$244.00Buy$0.0000.00% ROIEVHEvolent Health1/9/2026Lower Price Target$4.19$6.00Buy$0.0000.00% ROICTEVClaritev1/9/2026Lower Price Target$28.96$63.00Buy$0.0000.00% ROIWAYWaystar1/9/2026Lower Price Target$33.49$46.00Buy$0.0000.00% ROITDOCTeladoc Health1/9/2026Lower Price Target$7.44$9.00Neutral$0.0000.00% ROIPHRPhreesia1/9/2026Lower Price Target$16.97$25.00Buy$0.0000.00% ROIHCATHealth Catalyst1/9/2026Lower Price Target$2.40$2.75Neutral$0.0000.00% ROIGDRXGoodRx1/9/2026Lower Price Target$2.77$4.50Buy$0.0000.00% ROIEVHEvolent Health1/6/2026Reiterated Rating$3.97Market Outperform$0.0000.00% ROIPHRPhreesia12/9/2025Lower Price Target$15.56$29.00Buy$0.0000.00% ROIEVHEvolent Health11/21/2025Lower Price Target$4.18$9.50Buy$0.0000.00% ROIHCATHealth Catalyst11/11/2025Lower Price Target$2.70$3.25Neutral$0.0000.00% ROICTEVClaritev11/10/2025Boost Price Target$57.51$80.00Buy$0.0000.00% ROIWAYWaystar10/31/2025Boost Price Target$35.83$49.00Buy$0.0000.00% ROICAHCardinal Health10/31/2025Boost Price Target$190.65$190.00Neutral$0.0000.00% ROITDOCTeladoc Health10/21/2025Boost Price Target$8.77$10.50Neutral$0.0000.00% ROIMCKMcKesson9/24/2025Boost Price Target$739.48$860.00Buy$0.0000.00% ROIOMIOwens & Minor8/12/2025Reiterated Rating$4.65$7.00Buy$0.0000.00% ROIHCATHealth Catalyst8/8/2025Downgrade$2.83$3.50Neutral$0.0000.00% ROIWAYWaystar6/25/2025Initiated Coverage$38.71$45.00Buy$00.0000.00% ROICAHCardinal Health6/13/2025Reiterated Rating$160.43$170.00Neutral$000.0000.00% ROIHCATHealth Catalyst4/25/2025Lower Price Target$4.01$6.50Buy$0.0000.00% ROIIran War: What Happened at 1:11 P.M. Outside D.C.? (Ad)A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 trillion dollar financial story unfolding behind the Iran conflict. Addison Wiggin, founder of the Grey Swan Investment Fraternity, investigated the claims himself and found enough corroboration to bring the story forward. The full account follows the money behind the headlines and shows why the Iran situation may look very different than reported.See the full investigation into the Iran money trail nowTDOCTeladoc Health4/25/2025Lower Price Target$7.20$8.75Neutral$0.0000.00% ROIOMIOwens & Minor4/17/2025Lower Price Target$6.93$11.00Buy$0.0000.00% ROICAHCardinal Health1/10/2025Boost Price Target$122.56$129.00Neutral$000.0000.00% ROIEVHEvolent Health1/10/2025Lower Price Target$12.46$18.00Buy$0.0000.00% ROIGDRXGoodRx1/10/2025Lower Price Target$4.49$6.25Buy$0.0000.00% ROIHCATHealth Catalyst1/10/2025Lower Price Target$6.93$10.00Buy$0.0000.00% ROIMCKMcKesson1/10/2025Lower Price Target$587.93$677.00Buy$000.0000.00% ROICTEVClaritev1/10/2025Boost Price Target$12.15$12.50Neutral$00.0000.00% ROIPHRPhreesia1/10/2025Boost Price Target$26.32$35.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBMO Capital MarketsStifel NicolausCantor FitzgeraldSanford C. BernsteinWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD Cowen Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
